Acute Rejection in a Highly Sensitized Lung Transplant Recipient with Pre-formed Donor-directed Anti-HLA Class II Antibodies: Role of Bortezomib Therapy.
Stuckey LJ, Kamoun M, Wadhwa A, Samaniego M, Bartos C, Berry J, Mahidhara R, Chang AC, Chan KM.
Clinical Transplants 2009, Chapter 49
Abstract
Acute Rejection in a Highly Sensitized Lung Transplant Recipient with Pre-formed Donor-directed Anti-HLA Class II Antibodies: Role of Bortezomib Therapy.
- Product Code: CT09_CH49
- Availability: In Stock
-
$5.00